FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

DuPont Guerry

Research Profile

Disorders

Concepts & Ideas

Procedures

Case Control Studies

Chemicals & Drugs

Anatomy

Co-author Network

Publications

TOP 3
Thomas R Fears; DuPont Guerry; Allan Halpern; Elizabeth A Holly; Richard W Sagebiel; David E Elder; Margaret A Tucker
Sunbeds and sunlamps: who used them and their risk for melanoma.
Sook Jung Yun; Phyllis A Gimotty; Wei-Ting Hwang; Peter Dawson; Patricia Van Belle; David E Elder; Rosalie Elenitsas; Lynn Schuchter; Paul J Zhang; DuPont Guerry; Xiaowei Xu
High lymphatic vessel density and lymphatic invasion underlie the adverse prognostic effect of radial growth phase regression in melanoma.
Phyllis A Gimotty; DuPont Guerry
Prognostication in thin cutaneous melanomas.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of DuPont Guerry (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Thomas R Fears; DuPont Guerry; Allan Halpern; Elizabeth A Holly; Richard W Sagebiel; David E Elder; Margaret A Tucker
Sunbeds and sunlamps: who used them and their risk for melanoma.
Pigment cell & melanoma research 2011;24(3):574-81.
2011: Sook Jung Yun; Phyllis A Gimotty; Wei-Ting Hwang; Peter Dawson; Patricia Van Belle; David E Elder; Rosalie Elenitsas; Lynn Schuchter; Paul J Zhang; DuPont Guerry; Xiaowei Xu
High lymphatic vessel density and lymphatic invasion underlie the adverse prognostic effect of radial growth phase regression in melanoma.
The American journal of surgical pathology 2011;35(2):235-42.
2010: Phyllis A Gimotty; DuPont Guerry
Prognostication in thin cutaneous melanomas.
Archives of pathology & laboratory medicine 2010;134(12):1758-63.
2010: Peter Kanetsky; Saarene Panossian; David E Elder; DuPont Guerry; Michael E Ming; Lynn Schuchter; Timothy R Rebbeck
Does MC1R genotype convey information about melanoma risk beyond risk phenotypes?
Cancer 2010;116(10):2416-28.
2010: Jeremy A Brauer; Cooper C Wriston; Andrea B Troxel; Rosalie Elenitsas; Daniel B Shin; DuPont Guerry; Michael E Ming
Characteristics associated with early and late melanoma metastases.
Cancer 2010;116(2):415-23.
2009: Phyllis A Gimotty; Frank Yoon; Rachel Hammond; Paul Rosenbaum; DuPont Guerry
Therapeutic effect of sentinel lymph node biopsy in melanoma remains an open question.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(26):4236-8.
2008: Xiaowei Xu; Phyllis A Gimotty; DuPont Guerry; Giorgos Karakousis; Patricia Van Belle; Haohai Liang; kathleen montone; Theresa L Pasha; Michael E Ming; Geza Acs; Michael Feldman; Stephen Barth; Rachel Hammond; Rosalie Elenitsas; Paul J Zhang; David E Elder
Lymphatic invasion revealed by multispectral imaging is common in primary melanomas and associates with prognosis.
Human pathology 2008;39(6):901-9.
2008: Phyllis A Gimotty; DuPont Guerry; Keith Flaherty
Using benchmarks based on historical survival rates for screening new therapies for stage IV melanoma patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(4):517-8.
2007: Ross M Levy; Michael E Ming; Michael Shapiro; Margaret Tucker; DuPont Guerry; Victoria A Cirillo-Hyland; Rosalie Elenitsas
Eruptive disseminated Spitz nevi.
Journal of the American Academy of Dermatology 2007;57(3):519-23.
2007: Giorgos C Karakousis; Phyllis A Gimotty; Brian J Czerniecki; David E Elder; Rosalie Elenitsas; Michael E Ming; Douglas L Fraker; DuPont Guerry; Francis R Spitz
Regional nodal metastatic disease is the strongest predictor of survival in patients with thin vertical growth phase melanomas: a case for SLN Staging biopsy in these patients.
Annals of surgical oncology 2007;14(5):1596-603.
2007: Rolf Swoboda; Rajasekharan Somasundaram; Laura Caputo; Elizabeth M Ochoa; Phyllis A Gimotty; Francesco M Marincola; Patricia Van Belle; Stephen Barth; David E Elder; DuPont Guerry; Brian J Czerniecki; Lynn Schuchter; Robert H Vonderheide; Dorothee Herlyn
Shared MHC class II-dependent melanoma ribosomal protein L8 identified by phage display.
Cancer research 2007;67(8):3555-9.
2007: Phyllis A Gimotty; David E Elder; Douglas L Fraker; Jeffrey Botbyl; Kimberly Sellers; Rosalie Elenitsas; Michael E Ming; Lynn Schuchter; Francis R Spitz; Brian J Czerniecki; DuPont Guerry
Identification of high-risk patients among those diagnosed with thin cutaneous melanomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(9):1129-34.
2007: C Suzanne Lea; Elizabeth A Holly; Patricia Hartge; Jennifer Shuwen Lee; DuPont Guerry; David E Elder; Allan C Halpern; Richard W Sagebiel; Margaret A Tucker
Reproductive risk factors for cutaneous melanoma in women: a case-control study.
American journal of epidemiology 2007;165(5):505-13.
2006: Laura L Kruper; Francis R Spitz; Brian J Czerniecki; Douglas L Fraker; Anne Blackwood-Chirchir; Michael E Ming; David E Elder; Rosalie Elenitsas; DuPont Guerry; Phyllis A Gimotty
Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma.
Cancer 2006;107(10):2436-45.
2006: David T Dicker; Jeremy Lerner; Patricia Van Belle; Stephen F Barth; DuPont Guerry; Meenhard Herlyn; David E Elder; Wafik S El-Deiry
Differentiation of normal skin and melanoma using high resolution hyperspectral imaging.
Cancer biology & therapy 2006;5(8):1033-8.
2006: Thomas R Fears; DuPont Guerry; Ruth M Pfeiffer; Richard W Sagebiel; David E Elder; Allan C Halpern; Elizabeth A Holly; Patricia Hartge; Margaret A Tucker
Identifying individuals at high risk of melanoma: a practical predictor of absolute risk.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(22):3590-6.
2006: Giorgos C Karakousis; Phyllis A Gimotty; Jeffrey Botbyl; Susan Kesmodel; David E Elder; Rosalie Elenitsas; Michael E Ming; DuPont Guerry; Douglas L Fraker; Brian J Czerniecki; Francis R Spitz
Predictors of regional nodal disease in patients with thin melanomas.
Annals of surgical oncology 2006;13(4):533-41.
2006: Rajasekharan Somasundaram; Rolf Swoboda; Laura Caputo; Laszlo Otvos; Barbara Weber; Patricia Volpe; Patricia Van Belle; Susan Hotz; David E Elder; Francesco M Marincola; Lynn Schuchter; DuPont Guerry; Brian J Czerniecki; Dorothee Herlyn
Human leukocyte antigen-A2-restricted CTL responses to mutated BRAF peptides in melanoma patients.
Cancer research 2006;66(6):3287-93.
2006: Tianqian Zhang; Rajasekharan Somasundaram; Klara Berencsi; Laura Caputo; Phyllis A Gimotty; Pyapalli Rani; DuPont Guerry; Rolf Swoboda; Dorothee Herlyn
Migration of cytotoxic T lymphocytes toward melanoma cells in three-dimensional organotypic culture is dependent on CCL2 and CCR4.
European journal of immunology 2006;36(2):457-67.
2005: Rajasekharan Somasundaram; Laura Caputo; DuPont Guerry; Dorothee Herlyn
CD8+, HLA-unrestricted, cytotoxic T-lymphocyte line against malignant melanoma.
Journal of translational medicine 2005;3():41.
2005: Phyllis A Gimotty; Jeffrey Botbyl; Seng-Jaw Soong; DuPont Guerry
A population-based validation of the American Joint Committee on Cancer melanoma staging system.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(31):8065-75.
2005: Phyllis A Gimotty; Patricia Van Belle; David E Elder; Todd Murry; Kathleen T Montone; Xiaowei Xu; Susan Hotz; Shane Raines; Michael E Ming; Peter Wahl; DuPont Guerry
Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(31):8048-56.
2005: David E Elder; Phyllis A Gimotty; DuPont Guerry
Cutaneous melanoma: estimating survival and recurrence risk based on histopathologic features.
Dermatologic therapy 2005;18(5):369-85.
2005: Susan Kesmodel; Giorgos C Karakousis; Jeffrey Botbyl; Robert Canter; Robert T Lewis; Peter M Wahl; Kyla P Terhune; Abass Alavi; David E Elder; Michael E Ming; DuPont Guerry; Phyllis A Gimotty; Douglas L Fraker; Brian J Czerniecki; Francis R Spitz
Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas.
Annals of surgical oncology 2005;12(6):449-58.
2005: Tianqian Zhang; Rajasekharan Somasundaram; Klara Berencsi; Laura Caputo; Pyapalli Rani; DuPont Guerry; Emma E Furth; Barrett J Rollins; Mary E Putt; Phyllis A Gimotty; Rolf Swoboda; Meenhard Herlyn; Dorothee Herlyn
CXC chemokine ligand 12 (stromal cell-derived factor 1 alpha) and CXCR4-dependent migration of CTLs toward melanoma cells in organotypic culture.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(9):5856-63.
2004: Joni L Rutter; Christina M Bromley; Alisa M Goldstein; David E Elder; Elizabeth A Holly; DuPont Guerry; Patricia Hartge; Jeffery Struewing; David Hogg; Allan C Halpern; Richard W Sagebiel; Margaret A Tucker
Heterogeneity of risk for melanoma and pancreatic and digestive malignancies: a melanoma case-control study.
Cancer 2004;101(12):2809-16.
2004: Phyllis A Gimotty; DuPont Guerry; Michael E Ming; Rosalie Elenitsas; Xiaowei Xu; Brian J Czerniecki; Francis R Spitz; Lynn Schuchter; David E Elder
Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(18):3668-76.
2004: Amy E Millen; Margaret A Tucker; Patricia Hartge; Allan C Halpern; David E Elder; DuPont Guerry; Elizabeth A Holly; Richard W Sagebiel; Nancy Potischman
Diet and melanoma in a case-control study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004;13(6):1042-51.
2004: Janak N Shah; Douglas L Fraker; DuPont Guerry; Michael Feldman; Michael L Kochman
Melanoma seeding of an EUS-guided fine needle track.
Gastrointestinal endoscopy 2004;59(7):923-4.
2004: Peter Kanetsky; Fan Ge; Derek Najarian; Jennifer Swoyer; Saarene Panossian; Lynn Schuchter; Robin Holmes; DuPont Guerry; Timothy R Rebbeck
Assessment of polymorphic variants in the melanocortin-1 receptor gene with cutaneous pigmentation using an evolutionary approach.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004;13(5):808-19.
2003: Meenhard Herlyn; DuPont Guerry
First international melanoma research congress.
Cancer biology & therapy 2003;2(6):721-4.
2003: Jian Li; Weiping Li; Shaohong Liang; Dewei Cai; Marie Paule Kieny; Lutz Jacob; Alban Linnenbach; Jan W Abramczuk; Hans Bender; Katrin Sproesser; Rolf Swoboda; Rajasekharan Somasundaram; DuPont Guerry; Dorothee Herlyn
Recombinant CD63/ME491/neuroglandular/NKI/C-3 antigen inhibits growth of established tumors in transgenic mice.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(6):2922-9.
2003: Rajasekharan Somasundaram; Rolf Swoboda; Laura Caputo; Allana Lee; Naidine Jackson; Francesco M Marincola; DuPont Guerry; Dorothee Herlyn
A CD4+, HLA-DR7-restricted T-helper lymphocyte clone recognizes an antigen shared by human malignant melanoma and glioma.
International journal of cancer. Journal international du cancer 2003;104(3):362-8.
2003: Saroj Basak; Brigitte Birebent; Enkhtsetseg Purev; Rajasekharan Somasundaram; Haruhiko Maruyama; Jan Zaloudik; Rolf Swoboda; Wolfgang Strittmatter; Weiping Li; Albrecht Luckenbach; Hong Song; Jian Li; Katrin Sproesser; DuPont Guerry; Sridar Nair; Koichi Furukawa; Dorothee Herlyn
Induction of cellular immunity by anti-idiotypic antibodies mimicking GD2 ganglioside.
Cancer immunology, immunotherapy : CII 2003;52(3):145-54.
2002: Timothy D Anderson; Randal S Weber; DuPont Guerry; David E Elder; Lynn Schuchter; Laurie A Loevner; David I Rosenthal
Desmoplastic neurotropic melanoma of the head and neck: the role of radiation therapy.
Head & neck 2002;24(12):1068-71.
2002: Phyllis A Gimotty; DuPont Guerry; David E Elder
Validation of prognostic models for melanoma.
American journal of clinical pathology 2002;118(4):489-91.
2002: Timothy R Rebbeck; Peter Kanetsky; Amy H Walker; Robin Holmes; Allan C Halpern; Lynn Schuchter; David E Elder; DuPont Guerry
P gene as an inherited biomarker of human eye color.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002;11(8):782-4.
2002: Thomas R Fears; Cameron C Bird; DuPont Guerry; Richard W Sagebiel; Mitchell H Gail; David E Elder; Allan C Halpern; Elizabeth A Holly; Patricia Hartge; Margaret A Tucker
Average midrange ultraviolet radiation flux and time outdoors predict melanoma risk.
Cancer research 2002;62(14):3992-6.
2002: Karen S McGinnis; Stuart R Lessin; David E Elder; DuPont Guerry; Lynn Schuchter; Michael E Ming; Rosalie Elenitsas
Pathology review of cases presenting to a multidisciplinary pigmented lesion clinic.
Archives of dermatology 2002;138(5):617-21.
2002: M Anne Blackwood; Robin Holmes; Marie Synnestvedt; Megan Young; Cicily George; Hannah Yang; David E Elder; Lynn Schuchter; DuPont Guerry; Arupa Ganguly
Multiple primary melanoma revisited.
Cancer 2002;94(8):2248-55.
2002: Peter Kanetsky; Jennifer Swoyer; Saarene Panossian; Robin Holmes; DuPont Guerry; Timothy R Rebbeck
A polymorphism in the agouti signaling protein gene is associated with human pigmentation.
American journal of human genetics 2002;70(3):770-5.
2001: Peter Kanetsky; Robin Holmes; A Walker; Derek Najarian; Jennifer Swoyer; DuPont Guerry; Allan C Halpern; Timothy R Rebbeck
Interaction of glutathione S-transferase M1 and T1 genotypes and malignant melanoma.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2001;10(5):509-13.
2001: John K Wildemore; Lynn Schuchter; Rosemarie Mick; Marie Synnestvedt; Rosalie Elenitsas; Isabelle Bedrosian; Brian J Czerniecki; DuPont Guerry; Stuart R Lessin; David E Elder; Louis P Bucky
Locally recurrent malignant melanoma characteristics and outcomes: a single-institution study.
Annals of plastic surgery 2001;46(5):488-94.
2000: Isabelle Bedrosian; Mark Faries; DuPont Guerry; Rosalie Elenitsas; Lynn Schuchter; Rosemarie Mick; Francis R Spitz; Louis P Bucky; Abass Alavi; David E Elder; Douglas L Fraker; Brian J Czerniecki
Incidence of sentinel node metastasis in patients with thin primary melanoma (< or = 1 mm) with vertical growth phase.
Annals of surgical oncology 2000;7(4):262-7.
2000: Rajasekharan Somasundaram; P Robbins; Dilip Moonka; E Loh; Francesco M Marincola; A Patel; DuPont Guerry; Dorothee Herlyn
CD4(+), HLA class I-restricted, cytolytic T-lymphocyte clone against primary malignant melanoma cells.
International journal of cancer. Journal international du cancer 2000;85(2):253-9.
1999: Patricia Van Belle; Rosalie Elenitsas; Kapaettu Satyamoorthy; J T Wolfe; DuPont Guerry; L Schuchter; T J Van Belle; S Albelda; P Tahin; Meenhard Herlyn; David E Elder
Progression-related expression of beta3 integrin in melanomas and nevi.
Human pathology 1999;30(5):562-7.
1998: H K Boxhorn; JG Smith; Y J Chang; DuPont Guerry; William M F Lee; U Rodeck; Laurence A Turka; Stephen L Eck
Adenoviral transduction of melanoma cells with B7-1: antitumor immunity and immunosuppressive factors.
Cancer immunology, immunotherapy : CII 1998;46(5):283-92.
1998: Ralf Gutzmer; DuPont Guerry
Gene therapy for melanoma in humans.
Hematology/oncology clinics of North America 1998;12(3):519-38.
1997: KK Sanford; R Parshad; FM Price; Robert E Tarone; J Thompson; DuPont Guerry
Radiation-induced chromatid breaks and DNA repair in blood lymphocytes of patients with dysplastic nevi and/or cutaneous melanoma.
The Journal of investigative dermatology 1997;109(4):546-9.
1997: Margaret A Tucker; Allan C Halpern; Elizabeth A Holly; Patricia Hartge; David E Elder; Richard W Sagebiel; DuPont Guerry; Wallace H Clark
Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma.
JAMA : the journal of the American Medical Association 1997;277(18):1439-44.
1997: Kevin K Anbari; Lynn Schuchter; Louis P Bucky; Rosemarie Mick; Marie Synnestvedt; DuPont Guerry; R Hamilton; Allan C Halpern
Melanoma of unknown primary site: presentation, treatment, and prognosis--a single institution study. University of Pennsylvania Pigmented Lesion Study Group.
Cancer 1997;79(9):1816-21.
1996: David E Elder; Patricia Van Belle; Rosalie Elenitsas; Allan C Halpern; DuPont Guerry
Neoplastic progression and prognosis in melanoma.
Seminars in cutaneous medicine and surgery 1996;15(4):336-48.
1996: Lynn Schuchter; D J Schultz; Marie Synnestvedt; Bruce J Trock; DuPont Guerry; David E Elder; Rosalie Elenitsas; W H Clark; Allan C Halpern
A prognostic model for predicting 10-year survival in patients with primary melanoma. The Pigmented Lesion Group.
Annals of internal medicine 1996;125(5):369-75.
1995: Patricia Hartge; E A Holly; Allan C Halpern; R Sagebiel; DuPont Guerry; David E Elder; W Clark; L Hanson; C Harrison; Robert E Tarone
Recognition and classification of clinically dysplastic nevi from photographs: a study of interobserver variation.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1995;4(1):37-40.
1994: W P Carey; C J Thompson; Marie Synnestvedt; DuPont Guerry; Allan C Halpern; D Schultz; David E Elder
Dysplastic nevi as a melanoma risk factor in patients with familial melanoma.
Cancer 1994;74(12):3118-25.
1994: Allan C Halpern; Lynn Schuchter; David E Elder; DuPont Guerry; Rosalie Elenitsas; Bruce J Trock; I Matozzo
Effects of topical tretinoin on dysplastic nevi.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(5):1028-35.
1993: Jeannette L Bennicelli; DuPont Guerry
Production of multiple cytokines by cultured human melanomas.
Experimental dermatology 1993;2(4):186-90.
1993: Allan C Halpern; DuPont Guerry; David E Elder; Bruce J Trock; Marie Synnestvedt; T Humphreys
Natural history of dysplastic nevi.
Journal of the American Academy of Dermatology 1993;29(1):51-7.
1993: Margaret A Tucker; Mary C Fraser; Alisa M Goldstein; David E Elder; DuPont Guerry; S M Organic
Risk of melanoma and other cancers in melanoma-prone families.
The Journal of investigative dermatology 1993;100(3):350S-355S.
1993: Allan C Halpern; DuPont Guerry; David E Elder; Bruce J Trock; Marie Synnestvedt
A cohort study of melanoma in patients with dysplastic nevi.
The Journal of investigative dermatology 1993;100(3):346S-349S.
1993: DuPont Guerry; Marie Synnestvedt; David E Elder; D Schultz
Lessons from tumor progression: the invasive radial growth phase of melanoma is common, incapable of metastasis, and indolent.
The Journal of investigative dermatology 1993;100(3):342S-345S.
1993: David E Elder; W H Clark; Rosalie Elenitsas; DuPont Guerry; Allan C Halpern
The early and intermediate precursor lesions of tumor progression in the melanocytic system: common acquired nevi and atypical (dysplastic) nevi.
Seminars in diagnostic pathology 1993;10(1):18-35.
1992: E J Miller; John M Daly; Marie Synnestvedt; D Schultz; David E Elder; DuPont Guerry
Loco-regional nodal relapse in melanoma.
Surgical oncology 1992;1(5):333-40.
1992: DuPont Guerry; Lynn Schuchter
Disseminated melanoma--is there a new standard therapy?
The New England journal of medicine 1992;327(8):560-1.
1991: Meenhard Herlyn; Ullrich Graeven; D Speicher; B A Sela; Jeannette L Bennicelli; R Kath; DuPont Guerry
Characterization of tenascin secreted by human melanoma cells.
Cancer research 1991;51(18):4853-8.
1991: Allan C Halpern; DuPont Guerry; David E Elder; W H Clark; Marie Synnestvedt; Sandra A Norman; R Ayerle
Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case-control study.
Archives of dermatology 1991;127(7):995-9.
1991: U Shabon; Jeannette L Bennicelli; DuPont Guerry; Hilary Koprowski; R P Ricciardi
Human melanoma cells transcribe interleukin 1 genes identical to those of monocytes.
Cancer research 1991;51(12):3334-5.
1991: Barrie R Cassileth; E J Lusk; DuPont Guerry; A D Blake; W P Walsh; L Kascius; D J Schultz
Survival and quality of life among patients receiving unproven as compared with conventional cancer therapy.
The New England journal of medicine 1991;324(17):1180-5.
1990: G D Masri; Wallace H Clark; DuPont Guerry; Allan C Halpern; C J Thompson; David E Elder
Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease.
Journal of the American Academy of Dermatology 1990;22(6 Pt 1):1042-8.
1989: W H Clark; David E Elder; DuPont Guerry; L E Braitman; Bruce J Trock; D Schultz; Marie Synnestvedt; Allan C Halpern
Model predicting survival in stage I melanoma based on tumor progression.
Journal of the National Cancer Institute 1989;81(24):1893-904.
1989: B A Sela; D Iliopoulos; DuPont Guerry; Dorothee Herlyn; Hilary Koprowski
Levels of disialogangliosides in sera of melanoma patients monitored by sensitive thin-layer chromatography and immunostaining.
Journal of the National Cancer Institute 1989;81(19):1489-92.
1989: M A Alexander; Jeannette L Bennicelli; DuPont Guerry
Defective antigen presentation by human melanoma cell lines cultured from advanced, but not biologically early, disease.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(11):4070-8.
1989: Jeannette L Bennicelli; J Elias; J Kern; DuPont Guerry
Production of interleukin 1 activity by cultured human melanoma cells.
Cancer research 1989;49(4):930-5.
1988: Barrie R Cassileth; Lydia R Temoshok; B E Frederick; W P Walsh; S Hurwitz; DuPont Guerry; W H Clark; Ralph J DiClemente; D M Sweet; M S Blois
Patient and physician delay in melanoma diagnosis.
Journal of the American Academy of Dermatology 1988;18(3):591-8.
1987: DuPont Guerry; M A Alexander; D E Elder; M F Herlyn
Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma.
Journal of immunology (Baltimore, Md. : 1950) 1987;139(1):305-12.
1986: D Herlyn; David E Elder; E Bondi; B Atkinson; DuPont Guerry; H Koprowski; Wallace H Clark
Human cutaneous nevi transplanted onto nude mice: a model for the study of the lesional steps in tumor progression.
Cancer research 1986;46(3):1339-43.
1985: Meenhard Herlyn; J Thurin; G Balaban; Jeannette L Bennicelli; D Herlyn; David E Elder; E Bondi; DuPont Guerry; Peter C Nowell; Wallace H Clark
Characteristics of cultured human melanocytes isolated from different stages of tumor progression.
Cancer research 1985;45(11 Pt 2):5670-6.
1985: David E Elder; DuPont Guerry; M VanHorn; S Hurwitz; L Zehngebot; L I Goldman; D LaRossa; R Hamilton; E E Bondi; Wallace H Clark
The role of lymph node dissection for clinical stage I malignant melanoma of intermediate thickness (1.51-3.99 mm).
Cancer 1985;56(2):413-8.
1985: Meenhard Herlyn; G Balaban; Jeannette L Bennicelli; DuPont Guerry; R Halaban; D Herlyn; David E Elder; G G Maul; Z Steplewski; Peter C Nowell
Primary melanoma cells of the vertical growth phase: similarities to metastatic cells.
Journal of the National Cancer Institute 1985;74(2):283-9.
1985: M H Greene; Wallace H Clark; Margaret A Tucker; David E Elder; K H Kraemer; DuPont Guerry; W K Witmer; J Thompson; I Matozzo; Mary C Fraser
Acquired precursors of cutaneous malignant melanoma. The familial dysplastic nevus syndrome.
The New England journal of medicine 1985;312(2):91-7.
1984: Wallace H Clark; David E Elder; DuPont Guerry; M N Epstein; M H Greene; M Van Horn
A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma.
Human pathology 1984;15(12):1147-65.
1984: M R Taylor; DuPont Guerry; E E Bondi; J A Shields; J J Augsburger; E J Lusk; David E Elder; Wallace H Clark; M Van Horn
Lack of association between intraocular melanoma and cutaneous dysplastic nevi.
American journal of ophthalmology 1984;98(4):478-82.
1984: A H Ross; Meenhard Herlyn; C S Ernst; DuPont Guerry; Jeannette L Bennicelli; B F Ghrist; B Atkinson; H Koprowski
Immunoassay for melanoma-associated proteoglycan in the sera of patients using monoclonal and polyclonal antibodies.
Cancer research 1984;44(10):4642-7.
1984: G Balaban; Meenhard Herlyn; DuPont Guerry; R Bartolo; H Koprowski; Wallace H Clark; Peter C Nowell
Cytogenetics of human malignant melanoma and premalignant lesions.
Cancer genetics and cytogenetics 1984;11(4):429-39.
1984: M H Greene; Wallace H Clark; Margaret A Tucker; David E Elder; K H Kraemer; DuPont Guerry; Mary C Fraser
Managing the dysplastic naevus syndrome.
Lancet 1984;1(8369):166-7.
1984: M H Greene; Mary C Fraser; Wallace H Clark; David E Elder; DuPont Guerry; K H Kraemer
For the record: the history of precursors to malignant melanoma.
Archives of dermatology 1984;120(1):18-21.
1984: Meenhard Herlyn; B Lange; Jeannette L Bennicelli; M Blaszczyk; DuPont Guerry; H Koprowski
Increased levels of circulating HLA-DR antigen in sera of patients with acute lymphoblastoid leukemia.
Leukemia research 1984;8(3):323-34.
1983: K H Kraemer; M H Greene; R Tarone; David E Elder; W H Clark; DuPont Guerry
Dysplastic naevi and cutaneous melanoma risk.
Lancet 1983;2(8358):1076-7.
1983: E E Bondi; David E Elder; DuPont Guerry; Wallace H Clark
Target blue nevus.
Archives of dermatology 1983;119(11):919-20.
1983: Meenhard Herlyn; D Herlyn; David E Elder; E Bondi; D LaRossa; R Hamilton; H F Sears; G Balaban; DuPont Guerry; Wallace H Clark
Phenotypic characteristics of cells derived from precursors of human melanoma.
Cancer research 1983;43(11):5502-8.
1983: E E Bondi; David E Elder; DuPont Guerry; Wallace H Clark
Skin markings in malignant melanoma.
JAMA : the journal of the American Medical Association 1983;250(4):503-5.
1982: T M Keahey; DuPont Guerry; R J Tuthill; E E Bondi
Malignant angioendotheliomatosis proliferans treated with doxorubicin.
Archives of dermatology 1982;118(7):512-4.
1981: P Nowell; J Finan; D Glover; DuPont Guerry
Cytogenetic evidence for the clonal nature of Richter's syndrome.
Blood 1981;58(1):183-6.
1981: P Nowell; T V Shankey; J Finan; DuPont Guerry; E Besa
Proliferation, differentiation, and cytogenetics of chronic leukemic B lymphocytes cultured with mitomycin-treated normal cells.
Blood 1981;57(3):444-51.
1981: E E Bondi; Wallace H Clark; David E Elder; DuPont Guerry; M H Greene
Topical chemotherapy of dysplastic melanocytic nevi with 5% fluorouracil.
Archives of dermatology 1981;117(2):89-92.
1980: M H Greene; Wallace H Clark; Margaret A Tucker; David E Elder; K H Kraemer; Mary C Fraser; E E Bondi; DuPont Guerry; R Tuthill; R Hamilton; D LaRossa
Precursor naevi in cutaneous malignant melanoma: a proposed nomenclature.
Lancet 1980;2(8202):1024.
1980: Meenhard Herlyn; Wallace H Clark; M J Mastrangelo; DuPont Guerry; David E Elder; D LaRossa; R Hamilton; E Bondi; R Tuthill; Z Steplewski; H Koprowski
Specific immunoreactivity of hybridoma-secreted monoclonal anti-melanoma antibodies to cultured cells and freshly derived human cells.
Cancer research 1980;40(10):3602-9.